77 /100
CRITICAL RISK
Score updated May 16, 2026

WINT — Windtree Therapeutics, Inc. Dilution Risk Tracker

Track WINT dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track WINT — Get alerts when the score changes →

📊 Score Breakdown

📋 Offering Ability
60
💰 Cash Runway
95
📊 Float Risk
25
⚠️ Warrant Exposure
15
🔄Convertible Debt—

🌦️ Dilution Forecast

⛈️
Warning
High probability of dilution event
64%
🔄 Reverse Split 70%
• 50-day avg $0.02 below $1 exchange minimum
• Only 0 months cash — financial pressure
🔁 Convertible Conversion 60%
• Major convertible overhang: 229% potential dilution
• Convertible risk score very high (85/100)
💰 Capital Raise 55%
• Critical: only 0.1 months cash remaining
🔔 Track WINT — Get forecast alerts →

💹 Market Data

Market Cap$573.0K
Shares Outstanding33.71M
Float33.71M
Cash$204.0K
Debt$3.48M
Short InterestN/A

🏛 Institutional Holdings

0.0% institutional ownership
Source: Yahoo Finance · Detailed 13F holder data available for tracked tickers
🔔 Track WINT for full holder detail →

📉 Short Interest

Short Interest6.4K
Days to Cover1.0
% of Float0.0%
FINRA data as of Apr 30, 2026

📁 Recent SEC Activity

xbrl XBRL CONVERTIBLE Dec 31, 2024
xbrl XBRL WARRANT Dec 31, 2024
Full SEC filing analysis available with free account →

📰 Recent News

No recent news
Track WINT Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking WINT — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required
Similar risk profiles: CISO HCTI LBSR ONCO OTLK
🔬 More Research for WINT
📊 WINT FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 WINT Signal Convergence & Dark Pool Activity — StonkWhisper 📄 WINT Dilution Risk Analysis — Full In-Depth Report

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.